Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

The Free Radical Theory of Aging Matures

BECKMAN, K. B., & AMES, B. N. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.2.547 · Cited by 3,879 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

Lipid extraction of tissues with a low-toxicity solvent

Hara, A., & Radin, N. S. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90046-5 · Cited by 2,566 · see citing works

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works

Hydrogen peroxide mediates amyloid β protein toxicity

Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · see citing works

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · see citing works

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · see citing works

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · see citing works

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · see citing works

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296 · see citing works

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · see citing works

Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239 · see citing works

Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein.

Migaud, M., Charlesworth, P., Dempster, M., Webster, L. C., Watabe, A. M., Makhinson, M., He, Y., Ramsay, M. F., Morris, R. G. M., Morrison, J. H., et al. (1998) · Nature · doi:10.1038/24790 · Cited by 1,160 · see citing works

Nitric Oxide Scavenging by Curcuminoids

Sreejayan, & Rao, M. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,138 · see citing works

Risk of Alzheimer's disease and duration of NSAID use

Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132 · see citing works

Microglia: Intrinsic immuneffector cell of the brain

Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,111 · see citing works

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · see citing works

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · see citing works

Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876 · see citing works

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830 · see citing works

Amyloid β-Protein and the Genetics of Alzheimer's Disease

Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18295 · Cited by 798 · see citing works

Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex

Plummer, S. M., Holloway, K., Manson, M. M., Munks, R. J. L., Kaptein, A., Farrow, S. N., & Howells, L. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202980 · Cited by 627 · see citing works

Effects of environmental enrichment on gene expression in the brain

Rampon, C., Jiang, C. H., Dong, H., Tang, Y., Lockhart, D. J., Schultz, P. G., Tsien, J. Z., & Hu, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12880 · Cited by 614 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

Vitamin E protects nerve cells from amyloid βprotein toxicity

Behl, C., Davis, J. B., Cole, G. M., & Schubert, D. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90837-b · Cited by 582 · see citing works

The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging

Wang, J., Dickson, D. W., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7085 · Cited by 567 · see citing works

Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease

SZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562 · see citing works

Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547 · see citing works

PSD-95 Assembles a Ternary Complex with theN-Methyl-d-aspartic Acid Receptor and a Bivalent Neuronal NO Synthase PDZ Domain

Christopherson, K. S., Hillier, B. J., Lim, W. A., & Bredt, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27467 · Cited by 542 · see citing works

γ-Tocopherol traps mutagenic electrophiles such as NO x and complements α-tocopherol: Physiological implications

Christen, S., Woodall, A., Shigenaga, M. K., Southwell‐Keely, P. T., Duncan, M. W., & Ames, B. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3217 · Cited by 537 · see citing works

Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation

Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 508 · see citing works

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

Breitner, J. C. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00049-k · Cited by 466 · see citing works

Increased F ₂ ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation <i>in vivo</i>

Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · see citing works

In Vivo Inhibition of Nitric Oxide Synthase Gene Expression by Curcumin, a Cancer Preventive Natural Product with Anti-Inflammatory Properties

Chan, M. M.-Y., Huang, H., Fenton, M. R., & Fong, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00114-2 · Cited by 398 · see citing works

PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N -methyl- d -aspartate receptor subunit NR2A

Tezuka, T., Umemori, H., Akiyama, T., Nakanishi, S., & Yamamoto, T. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.435 · Cited by 377 · see citing works

β-Amyloid Stimulation of Inducible Nitric-oxide Synthase in Astrocytes Is Interleukin-1β- and Tumor Necrosis Factor-α (TNFα)-dependent, and Involves a TNFα Receptor-associated Factor- and NFκB-inducing Kinase-dependent Signaling Mechanism

Akama, K. T., & Eldik, L. J. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7918 · Cited by 356 · see citing works

Apolipoprotein E Polymorphism and Alzheimer Disease

Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 337 · see citing works

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Pappolla, M. A., Chyan, Y., Omar, R. A., Hsiao, K., Perry, G. L., Smith, M. A., & Bozner, P. (1998) · Europe PMC (PubMed Central) · Cited by 328 · see citing works

Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals

Zhao, B., Li, X., He, R., Cheng, S., & Wenjuan, X. (1989) · Cell Biophysics · doi:10.1007/bf02797132 · Cited by 322 · see citing works

Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia

McDonald, D. R., Brunden, K. R., & Landreth, G. E. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02284.1997 · Cited by 308 · see citing works

[Apolipoprotein E polymorphism and Alzheimer disease].

van der Weide, J., Steijns, L. S. W., Jl, T., Wj, N., & Klaverwijden, G. (1996) · PubMed · Cited by 297 · see citing works

Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce ?-amyloid fibrils

Frackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., & Wang, K. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227813 · Cited by 276 · see citing works

Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease

Montine, T., Markesbery, W., Morrow, J., & Roberts, L. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 254 · see citing works

Protective effects of idebenone and α‐tocopherol on β‐amyloid‐(1–42)‐induced learning and memory deficits in rats: implication of oxidative stress in β‐amyloid‐induced neurotoxicity in vivo

Yamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., & Nabeshima, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00408.x · Cited by 238 · see citing works

Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury

Thaloor, D., Miller, K. J., Gephart, J., Mitchell, P. O., & Pavlath, G. K. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c320 · Cited by 213 · see citing works

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation

Goodman, Y., Steiner, M. R., Steiner, S. M., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91586-5 · Cited by 202 · see citing works

Strategy and planning for chemopreventive drug development: Clinical development plans II

Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630705 · Cited by 196 · see citing works

Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium

Mattson, M. P., & Goodman, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00148-j · Cited by 188 · see citing works

CYCLOOXYGENASE-2 INHIBITORS

Masferrer, J. L., Isakson, P. C., & Seibert, K. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70252-1 · Cited by 165 · see citing works

Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia

Ding, M., Pierre, B. A. S., Parkinson, J. F., Medberry, P. S., Wong, J. L., Rogers, N. E., Ignarro, L. J., & Merrill, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11327 · Cited by 151 · see citing works

N-Methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease

Sze, C., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00467-6 · Cited by 146 · see citing works

Astroglial Expression of Human α1-Antichymotrypsin Enhances Alzheimer-like Pathology in Amyloid Protein Precursor Transgenic Mice

Mucke, L., Yu, G.-Q., McConlogue, L., Rockenstein, E. M., Abraham, C. R., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64839-0 · Cited by 145 · see citing works

The Soluble Form of Alzheimer′s Amyloid β Protein Is Complexed to High Density Lipoprotein 3 and Very High Density Lipoprotein in Normal Human Plasma

Koudinov, A. R., Matsubara, E., Frangione, B., & Ghiso, J. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2788 · Cited by 141 · see citing works

α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease

Nilsson, L. N. G., Bales, K. R., DiCarlo, G., Gordon, M. N., Morgan, D., Paul, S. M., & Potter, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01444.2001 · Cited by 137 · see citing works

Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits

Frautschy, S. A., Yang, F., Calderón, L., & Cole, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02073-x · Cited by 126 · see citing works

Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells.

Xu, Y. X., Pindolia, K. R., Janakiraman, N., Chapman, R. A., & Gautam, S. C. (1997) · PubMed · Cited by 123 · see citing works

Cyclo-Oxygenase-2 Inhibitors

McGeer, P. L. (2000) · Drugs & Aging · doi:10.2165/00002512-200017010-00001 · Cited by 116 · see citing works

The Magnitude of Brain Lipid Peroxidation Correlates with the Extent of Degeneration but Not with Density of Neuritic Plaques or Neurofibrillary Tangles or with APOE Genotype in Alzheimer's Disease Patients

Montine, T. J., Markesbery, W. R., Zackert, W. E., Sanchez, S. C., Roberts, L. J., & Morrow, J. D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65185-1 · Cited by 116 · see citing works

Microglial Contribution to Oxidative Stress in Alzheimer's Disease

Colton, C. A., Chernyshev, O. N., Gilbert, D. L., & Vitek, M. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06195.x · Cited by 94 · see citing works

Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease

Ishii, K., Tamaoka, A., Mizusawa, H., Shoji, S.-I., Ohtake, T., Fraser, P. E., Takahashi, H., Tsuji, S., Gearing, M., Mizutani, T., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01363-7 · Cited by 85 · see citing works

Solvent effects on beta protein toxicity in vivo

Waite, J., Cole, G. M., Frautschy, S. A., Connor, D. J., & Thal, L. J. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90062-3 · Cited by 84 · see citing works

N-Methyl- -Aspartate Receptor Antagonist MK-801 and Radical Scavengers Protect Cholinergic Nucleus Basalis Neurons against β-Amyloid Neurotoxicity

Harkany, T., Mulder, J., Sasvári, M., Ábrahám, I. M., Kónya, C., Zarándi, M., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0230 · Cited by 73 · see citing works

Involvement of free oxygen radicals in β-amyloidosis: An hypothesis

Friedlich, A. L., & Butcher, L. L. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90076-0 · Cited by 67 · see citing works

Lack of long-term effects after β-amyloid protein injections in rat brain

Winkler, J., Connor, D. J., Frautschy, S. A., Behl, C., Waite, J. J., Cole, G. M., & Thal, L. J. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00054-9 · Cited by 67 · see citing works

Protease inhibitor coinfusion with amyloid β-protein results in enhanced deposition and toxicity in rat brain

Frautschy, S. A., Horn, D. L., Sigel, J. J., Harris-White, M. E., Mendoza, J. J., Yang, F., Saido, T. C., & Cole, G. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08311.1998 · Cited by 65 · see citing works

Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid.

Bannwarth, B., Lapicque, F., Péhourcq, F., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05783.x · Cited by 61 · see citing works

Microglial Response to Transient Focal Cerebral Ischemia: An Immunocytochemical Study on the Rat Cerebral Cortex Using Anti-Phosphotyrosine Antibody

Korematsu, K., Goto, S., Nagahiro, S., & Ushio, Y. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.103 · Cited by 59 · see citing works

Effects of Transforming Growth Factor-β (Isoforms 1–3) on Amyloid-β Deposition, Inflammation, and Cell Targeting in Organotypic Hippocampal Slice Cultures

Harris‐White, M. E., Chu, T., Balverde, Z., Sigel, J. J., Flanders, K. C., & Frautschy, S. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10366.1998 · Cited by 55 · see citing works

Estrogen (E2) and glucocorticoid (Gc) effects on microglia and Aβ clearance in vitro and in vivo

Harris‐White, M. E., Chu, T., Miller, S., Simmons, M., Teter, B., Nash, D., Cole, G. M., & Frautschy, S. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00051-1 · Cited by 48 · see citing works

Monoclonal antibody to the C-terminus of β-amyloid

Yang, F., Mak, K., Vinters, H. V., Frautschy, S. A., & Cole, G. M. (1994) · Neuroreport · doi:10.1097/00001756-199410270-00032 · Cited by 45 · see citing works

Effects of catechins on human blood platelet aggregation and lipid peroxidation

Neiva, T. J. C., de Morais, L. C. S. L., Polack, M., Simões, C. M. O., & D’Amico, É. A. (1999) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199911)13:7 · Cited by 44 · see citing works

Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats

Kaul, S., & Krishnakantha, T. P. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006829010327 · Cited by 37 · see citing works

Microglial tyrosine phosphorylation systems in normal and degenerating brain

Karp, H. L., Tillotson, M. L., Soria, J., Reich, C. A., & Wood, J. G. (1994) · Glia · doi:10.1002/glia.440110310 · Cited by 37 · see citing works

Relationship between oxidative stress and apoE phenotype in Alzheimer's disease

Ihara, Y., Hayabara, T., Sasaki, K., Kawada, R., Nakashima, Y., & Kuroda, S. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102006346.x · Cited by 29 · see citing works

Aβ and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity

Holcomb, L. A., Gordon, M. N., Benkovic, S. A., & Morgan, D. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00086-x · Cited by 17 · see citing works

Chronic intracerebroventricular exposure to β-amyloid(1-40) impairs object recognition but does not affect spontaneous locomotor activity or sensorimotor gating in the rat

Nag, S., Tang, F. M. K., & Yee, B. K. (2001) · Experimental Brain Research · doi:10.1007/s002210000561 · Cited by 17 · see citing works

Methods for Evaluating a Slice Culture Model of Alzheimer’s Disease

Harris‐White, M. E., Sigel, J. J., Frautschy, S. A., & Cole, G. M. (1999) · Springer eBooks · doi:10.1007/978-3-642-59916-3_4 · Cited by 6 · see citing works

Methods for Evaluating in Vivo Rodent Models for Alzheimer’s Disease

Frautschy, S. A., Chu, T., Sigel, J. J., et al. (1999) · Springer eBooks · doi:10.1007/978-3-642-59916-3_10 · Cited by 2 · see citing works

Untitled work

Cole (2000) · doi:10.1002/1097-0029(20000815)50:4

Untitled work

(2000) · doi:10.1002/1531-8249(200011)48:5

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · see citing works

Brain foods: The effects of nutrients on brain function.

Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372 · see citing works

Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior

Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · see citing works

Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease

Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604 · see citing works

The effect of curcumin (turmeric) on Alzheimer’s disease: An overview

Mishra, S., & Palanivelu, K. (2008) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.40220 · Cited by 599 · see citing works

Neuroprotective effects of curcumin

Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516 · see citing works

Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models

Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483 · see citing works

Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911829107 · Cited by 466 · see citing works

REVIEW: Curcumin and Alzheimer’s disease

Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience &amp; Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450 · see citing works

Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease

Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1630 · Cited by 317 · see citing works

Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease

Ahmed, T., & Gilani, A.-H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.010 · Cited by 301 · see citing works

Nutrition, Brain Aging, and Neurodegeneration: Table 1.

Joseph, J., Cole, G., Head, E., & Ingram, D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3520-09.2009 · Cited by 264 · see citing works

The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies

Voulgaropoulou, S. D., van Amelsvoort, T. A. M. J., Prickaerts, J., & Vingerhoets, C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146476 · Cited by 243 · see citing works

Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT)

Ishrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.002 · Cited by 230 · see citing works

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224 · see citing works

Neurotherapeutic applications of nanoparticles in Alzheimer’s disease

Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219 · see citing works

Clinical development of curcumin in neurodegenerative disease

Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179 · see citing works

Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms

Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00014 · Cited by 167 · see citing works

NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from <i>In Vitro</i> and Animal Models

COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129 · see citing works

Disease modifying therapy for AD?¹

Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117 · see citing works

Neuroinflammation: a potential therapeutic target

Craft, J. M., Watterson, D. M., & Van Eldik, L. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.887 · Cited by 116 · see citing works

Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108 · see citing works

Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer’s Disease

Sundaram, J. R., Poore, C. P., Sulaimee, N. H. B., Pareek, T., Cheong, W. F., Wenk, M. R., Pant, H. C., Frautschy, S. A., Low, C.-M., & Kesavapany, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170093 · Cited by 105 · see citing works

Nutrition and AGE‐ing: Focusing on Alzheimer’s Disease

Abate, G., Marziano, M., Rungratanawanich, W., Memo, M., & Uberti, D. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7039816 · Cited by 103 · see citing works

Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease

Parachikova, A., Green, K. N., Hendrix, C., & LaFerla, F. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014015 · Cited by 87 · see citing works

Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow

Awasthi, H., Tota, S., Hanif, K., Nath, C., & Shukla, R. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.007 · Cited by 86 · see citing works

Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model

Isik, A. T., Celik, T., Ulusoy, G., Ongoru, O., Elibol, B., Doruk, H., Bozoglu, E., Kayir, H., Mas, M. R., & Akman, S. (2009) · AGE · doi:10.1007/s11357-008-9078-8 · Cited by 76 · see citing works

Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti‐inflammatory drugs: The Cache County Study

Fotuhi, M., Zandi, P. P., Hayden, K. M., Khachaturian, A. S., Szekely, C. A., Wengreen, H., Munger, R. G., Norton, M. C., Tschanz, J. T., Lyketsos, C. G., et al. (2008) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2008.01.004 · Cited by 71 · see citing works

Neuroprotective activity of<scp>L</scp>-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum

Thangarajan, S., Deivasigamani, A., Natarajan, S. S., Krishnan, P., & Mohanan, S. K. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.872642 · Cited by 71 · see citing works

Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions

Walker, D., & Lue, L.-F. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793667 · Cited by 66 · see citing works

Review: Experimental manipulations of microglia in mouse models of <scp>A</scp>lzheimer's pathology: activation reduces amyloid but hastens tau pathology

Lee, D. C., Rizer, J., Hunt, J. B., Selenica, M. ‐. B., Gordon, M. N., & Morgan, D. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12002 · Cited by 57 · see citing works

Effect of Curcumin on Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress in Rats

Kumar, A., Naidu, P. S., Seghal, N., & Padi, S. S. V. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.076 · Cited by 45 · see citing works

Review paper Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin?

Pluta, R., Bogucka-Kocka, A., Ułamek-Kozioł, M., Furmaga-Jabłońska, W., Januszewski, S., Brzozowska, J., Jabłoński, M., & Kocki, J. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.52405 · Cited by 34 · see citing works

Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases

Hague, T., Andrews, P. L. R., Barker, J., & Naughton, D. P. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00008 · Cited by 12 · see citing works

Anti Oxidant Potential of “Cureit”- A Novel BioAvailable Curcumin Formulation

Gopia, S., Georgea, R., & .Sriraamb, V. T. (2014) · Asian Journal of Pharmaceutical Technology and Innovation · Cited by 5 · see citing works

Metabolic Fate of Curcumin in the Gastrointestinal Tract in Mice

Li, Z., Sun, Y., Song, M., et al. (2016) · The FASEB Journal · doi:10.1096/fasebj.30.1_supplement.690.9 · Cited by 1 · see citing works

Curcumin and Curcumin-like Molecules: From Spice to Drugs

Marchiani, A., Rozzo, C., Fadda, A., Delogu, G., & Ruzza, P. (2013) · Current Medicinal Chemistry · doi:10.2174/092986732102131206115810 · Cited by 194 · see citing works

P2‐435: GEPT extract prevents Aβ deposition–induced synaptic loss in APPV717I transgenic mice through improving synaptophysin

Shi, J., Tian, J., Wei, M., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2060

Evaluation of Curcumin Nanoparticles against Rabbit Skin Infection

Fatthi, D. A. (2023) · E3S Web of Conferences · doi:10.1051/e3sconf/202339101119